Clinical Trials Directory

Trials / Completed

CompletedNCT04941638

Comparison of Vascular Access in STEMI

Comparison of Distal Radial, Proximal Radial and Femoral Access in ST-Segment Elevation Myocardial Infarction

Status
Completed
Phase
Study type
Observational
Enrollment
109 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Distal radial access (DRA) has recently introduced and previous studies have demonstrated that it is feasible option, showing several advantages including less bleeding and access-site complications over proximal radial access (PRA). Previous study reported the feasibility of DRA as an alternative option for primary percutaneous coronary intervention (PCI) in STEMI patients without major complication. However, comparison study of each vascular access for primary PCI have not been conducted until now. Here, The investigators aim to compare the DRA, PRA and femoral access (FA), in terms of feasibility and safety, in patients with STEMI. This is a retrospective study with patients who underwent primary PCI for STEMI between March 2020 to May 2021. The primary outcome of this study is the access-site complication including major bleeding requiring transfusion or surgery, hematoma and arterial occlusion.

Detailed description

Recently, DRA has gained the interest of interventional cardiologists and previous studies have demonstrated several advantages including patient and operator comfort, shorter hemostasis duration, less bleeding, and access-site complications over PRA. More recently, randomized trial demonstrated that DRA prevents radial artery occlusion after the procedure compared with PRA. From this perspective, DRA could be considered an alternative access route for primary PCI in selected STEMI patients using potent P2Y12 inhibitors such as ticagrelor or prasugrel, or glycoprotein IIb/IIIa inhibitors.

Conditions

Interventions

TypeNameDescription
PROCEDUREDistal radial accessVascular access for primary PCI in patients with STEMI

Timeline

Start date
2021-06-17
Primary completion
2021-06-22
Completion
2021-06-29
First posted
2021-06-28
Last updated
2022-04-22

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04941638. Inclusion in this directory is not an endorsement.